Rydapt

Rydapt Coupons & Savings Card – Discount Prices from $6777.91

Midostaurin, marketed as Rydapt, is a targeted oral medication primarily used to treat certain blood cancers and immune disorders. It is effective for acute myeloid leukemia (AML) that is FLT3-positive, and is administered in combination with chemotherapy for newly diagnosed patients. Additionally, it is used to treat mast cell leukemia and systemic mastocytosis, conditions characterized by an overproduction of specific immune cells. Midostaurin functions as a tyrosine kinase inhibitor, blocking enzymes that encourage cancer cell growth, particularly in cells with the FLT3 mutation. Common side effects may include nausea, vomiting, and elevated blood sugar levels. Always consult healthcare professionals for personalized medical advice and before starting any new treatment.
Our Rydapt coupons are free to use. You can print the coupon, email it to yourself, or receive the Rydapt coupon via text message. To get your free discount, show the pharmacist your Rydapt savings card which has the discounted coupon price. Use our filters below to edit the prescription box to match your needs. The Rydapt prices will update based on your prescription needs. Above our Rydapt coupons, you can change the location to see pharmacy prices in other areas. Our prescription discount card will update online with the specific pharmacy costs associated with your edits. Be sure to text, email, or print the Rydapt savings card code that you need after editing the prescription box and location field. Show the discount card to your pharmacist before paying.

My prescription

Edit

25MG, Rydapt (30 Capsules)

Select pharmacy

Pharmacy logo

Walgreens

$6777.91

COUPON PRICE

Rydapt savings card

Show this card to your pharmacist
Pharmacy logo

Walgreens

$6777.91

BIN

ID

PCN

GRP

019876

LH0B24FFD0

CHIPPO

LHX

Powered by

This card is not insurance

Related kinase inhibitors prescriptions

coupons from$11273.76 
coupons from$22822.87 
coupons from$20961.09Save 72%
coupons from$12702.07 
coupons from$7738.15Save 72%
coupons from$15126.18 
coupons from$3556.97Save 72%
coupons from$18288.9Save 72%

More prescriptions for leukemia

coupons from$5343.45Save 72%
coupons from$4423.5Save 79%
coupons from$6541.29Save 72%
coupons from$5928.28Save 72%
coupons from$1867.18Save 72%
coupons from$28.8Save 84%
coupons from$1144.45Save 74%
coupons from$21.03Save 69%

Related kinase inhibitors prescriptions

Scemblixcoupons from $11273.76
Iclusigcoupons from $22822.87
Alunbrig Save 72%coupons from $20961.09
Tepmetkocoupons from $12702.07
Tavalisse Save 72%coupons from $7738.15
Copiktracoupons from $15126.18
Inlyta Save 72%coupons from $3556.97
Imbruvica Save 72%coupons from $18288.9

More prescriptions for leukemia

Bosulif Save 72%coupons from $5343.45
Sprycel Save 79%coupons from $4423.5
Rituxan Hycela Save 72%coupons from $6541.29
Readysharp Dexamethasone Save 72%coupons from $5928.28
Siklos Save 72%coupons from $1867.18
Rayos Save 84%coupons from $28.8
Purixan Save 74%coupons from $1144.45
Nasacort Allergy 24hr Children Save 69%coupons from $21.03

Rydapt dosage forms

Use our Rydapt 25MG coupon with prices from $6777.91 for 30 Capsules.
DosageQuantityPrice fromPer unit
25MG30 Capsules$6777.91$225.93

Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.

Rydapt Warnings

This document provides crucial safety information regarding the use of the medication Rydapt (midostaurin). It is essential to understand the potential risks and necessary precautions. Please read the information thoroughly and consult your healthcare provider with any questions or concerns.

  • Respiratory Issues: Although rare, Rydapt (midostaurin) may lead to serious lung complications, such as inflammation or interstitial lung disease. Should you experience any new or worsening respiratory symptoms, contact your healthcare provider immediately. Discontinuation of the medication may be advised.

  • Risks During Pregnancy: Animal studies indicate that Rydapt (midostaurin) can cause harm to an unborn child if used during pregnancy. Therefore, it is not recommended for use by pregnant women. Females capable of becoming pregnant will be required to take a pregnancy test one week prior to starting the medication. It is important to use effective contraception while taking Rydapt (midostaurin) and for at least four months following the final dose. Male patients with partners who can become pregnant should also use contraception during treatment and for four months afterward. Notify your healthcare provider immediately if pregnancy occurs during this period.

Please ensure full understanding and adherence to these guidelines to maintain safety while using Rydapt (midostaurin).

Rydapt Side Effects

When taking this medication, some common side effects may occur, but they are usually mild and not a cause for concern. You may experience nausea, vomiting, diarrhea, stomach pain, mouth sores, constipation, hemorrhoids, headache, dizziness, tiredness, muscle or joint pain, or trouble sleeping. If these effects persist or worsen, it's advisable to consult your healthcare provider.

There is a possibility of experiencing some other side effects such as fever due to low white blood cell counts, high blood sugar levels, lower blood calcium levels, redness or ulcers in the mouth, abnormal blood cell counts, swelling in the hands and feet, and abnormal liver or pancreatic enzyme levels. Some individuals might also notice red, brown, or purple spots on the skin, joint stiffness, cough, trouble breathing, nosebleeds, rash, infections, sweating, or muscle or bone pain.

In rare instances, severe side effects could occur, demanding prompt medical attention. These include symptoms of lung problems such as cough, chest pain, or trouble breathing, fast or irregular heartbeat, severe dizziness, fainting, bloody vomit, black or tarry stool, increased thirst or urination, signs of kidney issues, or unexplained bruising or bleeding. Additionally, severe allergic reactions are highly uncommon but require immediate care if symptoms like rash, swelling, or breathing difficulties appear.

It's important to be aware of these side effects and seek medical advice if you experience any serious issues. Always communicate with your healthcare provider regarding any concerns you have while taking this medication.

Rydapt Interactions

Certain medications can influence how midostaurin is eliminated from the body, potentially altering its effectiveness. Medications such as rifamycins (e.g., Rifabutin), St. John's wort, and some seizure treatments like Carbamazepine and Phenytoin can interact with midostaurin in this way.
Rydapt FAQs
How does Rydapt work?

Rydapt (midostaurin) works by inhibiting multiple kinases, including FLT3 and KIT, which are involved in the signaling pathways that regulate cell growth and survival. By blocking these kinases, Rydapt helps to slow down or stop the growth of cancer cells, particularly in conditions like acute myeloid leukemia (AML) with FLT3 mutations and systemic mastocytosis.

Yes, midostaurin is considered a type of chemotherapy drug. It is a targeted therapy used to treat certain types of cancer, such as acute myeloid leukemia (AML) and advanced systemic mastocytosis.

Rydapt is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) who have a FLT3 mutation, as detected by an FDA-approved test. It is also indicated for the treatment of adults with aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL).

Rydapt is administered orally.

Midostaurin is a type of medication known as a kinase inhibitor. It is used primarily in the treatment of certain types of cancer, such as acute myeloid leukemia (AML) with a specific genetic mutation and advanced systemic mastocytosis.